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Hypergrowth mTORC1 Signals Translationally Activate the ARF
Tumor Suppressor Checkpoint
Alexander P. Miceli, Anthony J. Saporita, and Jason D. Weber
BRIGHT Institute, Department of Internal Medicine, Division of Molecular Oncology, and Department of Cell Biology and Physiology, Siteman Cancer Center, Washington
University School of Medicine, Saint Louis, Missouri, USA
The ARF tumor suppressor is a potent sensor of hyperproliferative cues emanating from oncogenic signaling. ARF responds to
these cues by eliciting a cell cycle arrest, effectively abating the tumorigenic potential of these stimuli. Prior reports have demon-
strated that oncogenic RasV12 signaling induces ARF through a mechanismmediated by the Dmp1 transcription factor. How-
ever, we now show that ARF protein is still induced in response to RasV12 in the absence ofDmp1 through the enhanced transla-
tion of existing ArfmRNAs. Here, we report that the progrowth Ras/tuberous sclerosis complex (TSC)/mTORC1 signaling
pathway regulates ARF protein expression and triggers ARF-mediated tumor suppression through a novel translational mecha-
nism. Hyperactivation of mTORC1 through Tsc1 loss resulted in a significant increase in ARF expression, activation of the p53
pathway, and a dramatic cell cycle arrest, which were completely reversed upon Arf deletion. ARF protein induced from RasV12 in
the absence ofDmp1 repressed anchorage-independent colony formation in soft agar and tumor burden in an allograft model.
Taken together, our data demonstrate the ability of the ARF tumor suppressor to respond to hypergrowth stimuli to prevent
unwarranted tumor formation.
Regulatory checkpoints are key for maintaining homeostasis inthe cell. Transit through the mammalian cell cycle is tightly
regulated by a series of essential checkpoints that prevent progres-
sion in the presence of hyperproliferative signals or genotoxic in-
sults, such as DNA damage, a stalled replication fork, or improper
spindle assembly (7, 9, 22). These and several other regulatory
checkpoints are so critical for cellular homeostasis that their loss
contributes to the deleterious events that are among the hallmarks
of cancer (12).
The ARF tumor suppressor functions as an important check-
point in the cell, acting as a key sensor of hyperproliferative sig-
nals. ARF is one of the two tumor suppressors encoded by the
CDKN2A (Ink4a/Arf) locus (37). ARF functions in both p53-
dependent and p53-independent manners (42). Arf/ mice are
highly tumor prone, predominantly developing spontaneous fi-
brosarcoma and lymphoma malignancies (20, 21). Deletion or
silencing of the Ink4a/Arf locus through hypermethylation of the
promoters is extremely common in amultitude of human tumors;
among these are numerous examples where ARF function is spe-
cifically abrogated independently of p16INK4a (40). These obser-
vations underscore the significance of the antitumorigenic func-
tions of ARF and the necessity of cancer cells to evade ARF tumor
suppression.
Basal expression of ARF is nearly undetectable. However, ARF
protein levels are robustly upregulated in response to excessive
proliferative cues, such as those emanating from the RasV12, Myc,
E1A, v-Abl, and E2F oncoproteins (3, 8, 34, 38, 56). Upon induc-
tion, ARFbindsMDM2, the E3 ligase responsible for targeting p53
for proteasome-mediated degradation (52). ARF’s sequestration
of MDM2 in the nucleolus allows p53 to accumulate in the nucle-
oplasm and to activate downstream targets that trigger cell cycle
arrest (53).
Cell proliferation and cell growth are intimately linked. As
such, proliferative and growth stimuli often invoke cross talk at
key signaling networks to properly regulate the timing of cell cycle
progression and protein synthesis. A key player in this regulation
is the mammalian target of rapamycin (mTOR) signal transduc-
tion pathway (36). mTOR is a conserved serine/threonine kinase
that assembles into two major multiprotein-containing com-
plexes, mTORC1 andmTORC2 (57), each of which is reported to
serve a unique function in the cell (29). mTORC1 contains Rap-
tor, LST8, Deptor, PRAS40, and mTOR and is critical for regulat-
ing protein synthesis; mTORC2 includes Rictor, LST8, Deptor,
Protor, Sin1, andmTOR and plays a role in cytoskeletal organiza-
tion (57). mTOR responds to several upstream stimuli, including
growth factors and nutrients. Upstream signaling is propagated
through Ras and phosphatidylinositol 3-kinase (PI3K) (41). In
addition, the tuberous sclerosis complex (TSC) gene products are
critical upstreamnegative regulators ofmTORC1 signal transduc-
tion (15); loss of either Tsc1 or Tsc2 results in constitutive
mTORC1 signaling and increased phosphorylation of S6K1 (ribo-
somal protein S6 kinase 1) and initiation factor 4E binding protein
1 (4EBP1). This has direct consequences for the protein transla-
tion machinery and the downstream gene targets that are regu-
lated by this pathway (14). Mutations among pathway members
are common in hamartoma-forming syndromes and a broad
spectrum of human cancers (11, 13).
Given ARF’s central role in sensing hyperproliferative signals,
we hypothesized that ARF might also be sensitive to hypergrowth
cues emanating frommTORC1 signaling. In this report, we inves-
tigated ARF gene expression and function in response to hyperac-
tivation of the progrowth mTORC1 signal transduction pathway.
Importantly, we also interrogated ARF function in the absence of
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collaborating signals from theDmp1 transcription factor, the only
known regulator ofARF induction fromRasV12. RasV12 expression
inmurine embryonic fibroblasts (MEFs) lackingDmp1 resulted in
increased ARF protein levels, suggesting that (i) Dmp1-mediated
transcription of Arf is not obligatory for ARF induction and (ii-
another pathway downstream of Ras must modulate ARF expres-
sion. Using pharmacological and genetic manipulation, we now
show that the Ras/TSC/mTORC1 pathway regulates ARF through
a novel translational mechanism. Based on our findings, we pro-
pose that ARF can respond to hypergrowth signals emanating
from a hyperactivated mTORC1 pathway to prevent tumor for-
mation.
MATERIALS AND METHODS
Mice and cell culture. Tsc1flox/flox mice were a generous gift from Jeffrey
Arbeit (Washington University, St. Louis, MO) (23), with permission
from David Kwiatkowski (Harvard University, Cambridge, MA).
Tsc1flox/flox and Arf/ mice were intercrossed for several generations to
generate Tsc1flox/flox; Arf/ mice. Inbred homozygous female athymic
nude mice (Foxn1nu/Foxn1nu) were purchased from Jackson Laboratory
(Bar Harbor, ME). Nude mice were 5 weeks old at the time of purchase
and were housed in our facility until they were approximately 7 weeks of
age to acclimate to the new facility before injections were performed.
Low-passage (passage 3 [P3] to P5) primary murine embryonic fibro-
blasts for all described genotypes were established as previously described
(21) and maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum, 2 mM glutamine, 0.1 mM nones-
sential amino acids, 2 g/ml gentamicin. Etoposide (Sigma, St. Louis,
MO) and rapamycin (LC Laboratories, Woburn, MA) were, respectively,
used at final concentrations of 50 M and 100 nM.
Viral production and infections. pBabe-puro-H-RasV12 was a gener-
ous gift from Martine Roussel (St. Jude Children’s Research Hospital,
Memphis, TN). pBabe-HA-ARF (where HA is hemagglutinin), pWZL-
GFP-IRES-blast (where GFP is green fluorescent protein and blast is blas-
ticidin), and pWZL-RasV12-IRES-blast have been previously described (4,
51). Retroviral production was performed as previously described (4, 39).
Retroviral helper DNA was kindly provided by Charles Sawyers (Univer-
sity of California Los Angeles, Los Angeles, CA). Collected retrovirus was
used to infectMEFs in the presence of 10g/ml Polybrene. InfectedMEFs
were selected in 2 g/ml puromycin and were harvested for analysis at 5
days postinfection. For the production of lentiviruses encoding short
hairpin RNAs, 5 105 293T cells were cotransfected using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) with pHCMV.G, CMVR8.2, and
pLKO.1-puro constructs. Viral supernatants were collected and pooled.
InfectedMEFswere selected in 2g/ml puromycin andwere harvested for
analysis at 5 days postinfection. High-titer adenoviruses encoding
-galactosidase (Ad5CMVntLacZ [Ad-LacZ]) or Cre recombinase
(Ad5CMVCre [Ad-Cre]) were purchased from the Gene Transfer Vector
Core, University of Iowa. For adenovirus infections, MEFs were washed
with phosphate-buffered saline (PBS), trypsinized, and counted; 7.5 
105 cells were plated in the presence of LacZ- or Cre-encoding adenovirus
for 6 h. Cells were split upon reaching confluence and then harvested for
analysis at 9 to 10 days postinfection.
RNAi. pLKO.1-puro constructs obtained from the Genome Center at
Washington University were used for RNA interference (RNAi) against
Tsc1. Sequences for the short hairpin RNAs are 5=-GCCTCGTATGAAG
ATGGCTAT-3= for Tsc1 (here named siTSC1.2), 5=-GCCAGTGTTTAT
GCCCTCTTT-3= also for Tsc1 (here named siTSC1.4), 5=-GCGGTTGCC
AAGAGGTTCCAT-3= for the luciferase control, and 5=-CCTAAGGTTA
AGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3= for
the scrambled control. pLKO-GFP-shARF has been previously described
(1); for the present studies, the GFPmarker was replaced by a puromycin
resistance cassette subcloned into the BamHI and KpnI sites of pLKO.
Lentiviruses were packaged, and MEFs were infected as described above.
For RNAi against Raptor and Rictor, short hairpin RNA oligonucleotides
were purchased from Qiagen (Valencia, CA) and were transduced using
the Nucleofector system (Amaxa, Walkersville, MD) according to the
manufacturer’s instructions. Sequences for the short hairpin RNAs rec-
ognizing Raptor and Rictor, respectively, are 5=-CCGGGTCATGACTTA
CCGAGA-3= and 5=-CAGAAAGATGATTACTGTGAA-3=.
Western blotting.Harvested cells were resuspended and sonicated in
radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholic
acid) containing protease and phosphatase inhibitors (1 mM phenyl-
methylsulfonyl fluoride [PMSF], 0.4 U/ml aprotinin, 10g/ml leupeptin,
10 g/ml pepstatin, 1 mM -glycerophosphate, 0.1 mM NaF, 0.1 mM
NaVO4). Proteins (30 to 80g) were separated on 12.5% sodium dodecyl
sulfate (SDS)-containing polyacrylamide gels. Separated proteins were
transferred onto polyvinylidene difluoride (PVDF) membranes (Milli-
pore, Boston, MA). Membranes were probed with the following antibod-
ies: rabbit anti-Rictor (A300-459), rabbit anti-TSC1 (A300-316), and
rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDHj
A300-641) (all fromBethyl Laboratories;Montgomery, TX); rat anti-ARF
(ab26696; Abcam, Cambridge, MA); mouse anti-MDM2 (op115; Calbi-
ochem/EMD Chemicals, Gibbstown, NJ); mouse antiactin (sc8432),
mouse anti-p21 (sc6246), rabbit antinucleophosmin (anti-NPM; sc6013),
mouse anti--tubulin (sc17787), and rabbit anti-Ras (sc520) (all from
Santa Cruz Biotechnology, Santa Cruz, CA); rabbit anti-p53 (2524), rab-
bit anti-phospho-extracellular signal-regulated kinase 1 and 2 (anti-phos-
pho-ERK1/2), Thr 202/Tyr 204 (4377), rabbit anti-ERK1/2 (9102), rabbit
anti-phospho-S6, Ser 240/244 (2215), mouse anti-S6 (2317), rabbit anti-
Raptor (4978), rabbit anti-phospho-4EBP1, Thr37/46 (2855), rabbit anti-
YEBP1 (9452), and rabbit anti-p70 S6K1 (9202) (all from Cell Signaling
Technologies, Danvers, MA). Secondary horseradish peroxidase-
conjugated anti-rabbit, anti-rat, or anti-mouse antibodies (Jackson Im-
munoResearch, West Grove, PA) were added, and Amersham ECL Plus
(GE Healthcare, Piscataway, NJ) was used to visualize the bands.
Quantitative RT-PCR and endpoint PCR. Total RNA was extracted
from cells with a Nucleospin RNAII system (Clontech, Mountain View,
CA) according to the manufacturer’s instructions. Reverse transcription
(RT) reactions were performed using a SuperScript III first-strand syn-
thesis system (Invitrogen, Carlsbad, CA) with an oligo(dT) primer. Real-
time PCR was performed on an iCycler apparatus (Bio-Rad, Hercules,
CA) using iQ Sybr Green Supermix (Bio-Rad, Hercules, CA). Fold change
was calculated using theCT (whereCT is threshold cycle)method (28).
To measure ArfmRNA, the following primers were used: forward, 5=-GA
GTACAGCAGCGGGAGCAT-3=; reverse, 5=-ATCATCATCACCTGGTC
CAGGATTCC-3=. TomeasureGapdhmRNA, the following primers were
used: forward, 5=-GCTGGGGCTCACCTGAAGGG-3=; reverse: 5=-GGA
TGACCTTGCCCACAGCC-3=.
To assess the presence ofDmp1mRNA inMEF samples, total RNAwas
isolated, first-strand synthesis was used to generate cDNA with an oli-
go(dT) primer, and endpoint PCR analysis was performed. Primers used
for detectingDmp1were the following: forward, 5=-CTGTAGCTGAAAG
AGTGGGTA-3=; reverse, 5=-TGTATTATCTTCCAAGCGGGC-3= (19).
PCRs were separated on an agarose gel and stained with ethidium bro-
mide.
RNA and protein stability. Infected MEFs were treated with either 4
g/ml actinomycin D (Sigma, St. Louis, MO) to assess mRNA stability or
25g/ml cycloheximide (Sigma, St. Louis,MO) to assess protein stability.
Cells were harvested over a time course of 0, 2, 4, 6, or 8 h posttreatment
and subjected, respectively, to RNA isolation, cDNA synthesis reaction,
and quantitative reverse transcription-PCR (qRT-PCR) analysis or to
Western blot analysis.
Immunoprecipitation. Infected MEFs were freshly harvested, and
cells were resuspended and sonicated in EBC lysis buffer (50 mM Tris-
HCl, pH 7.4, 120 mMNaCl, 0.5%NP-40, 1 mM EDTA). Then, 300 g of
protein lysate was immunoprecipitated overnight with a rabbit anti-ARF
polyclonal antibody or normal rabbit IgG (sc2027; Santa Cruz Biotech-
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nology, Santa Cruz, CA). Immune complexes recovered by protein
A-Sepharose (GE Healthcare, Piscataway, NJ) were washed three times
with EBC buffer and were denatured. Proteins were separated on 12.5%
sodium dodecyl sulfate (SDS)-containing polyacrylamide gels and were
transferred onto PVDF membranes (Millipore, Boston, MA) and sub-
jected to direct immunoblotting as indicated.
Indirect IF andBrdU incorporation. InfectedMEFswere plated onto
coverslips. Cells were washed with PBS and fixed at room temperature
using 10% formalin–10% methanol, followed by incubation with 1%
NP-40 at room temperature for 5 min. Cells were stained with antibodies
recognizing ARF (ab26696; Abcam, Cambridge, MA) or MDM2 (op115;
Calbiochem/EMD Chemicals, Gibbstown, NJ, followed by the corre-
sponding secondary antibodies conjugated with Alexa Fluor 488 or Alexa
Fluor 594 (Invitrogen, Carlsbad, CA), respectively. Cells were then coun-
terstained for nuclei with SlowFade Gold Antifademounting reagent with
4=,6-diamidino-2-phenylindole (DAPI; Invitrogen, Carlsbad, CA). Fluo-
rescence signals were detected using a Nikon epifluorescent compound
microscope fitted with a Nikon FDX-35 charge-coupled-device camera.
For measurement of DNA replication, 5-bromodeoxyuridine (BrdU)
(Sigma, St. Louis, MO) was added to the culturingmedium for 2, 18 or 24
h, as indicated in the figure legends, at a final concentration of 10 M.
Cells were then treated for immunofluorescence (IF) analysis as noted
above and additionally incubatedwith 1.5NHCl at room temperature for
10 min. A mouse monoclonal antibody recognizing BrdU (Amer-
sham/GE Healthcare, Piscataway, NJ) was used.
Cell proliferation assay, focus formation, and soft-agar formation.
For cell proliferation assays, equal numbers of cells (5  104 Dmp1/
MEFs; 1  105 Tsc1flox/flox or Tsc1flox/flox; Arf/MEFs) were replated in
triplicate. Every 24 h thereafter, cells were harvested and counted using a
hemacytometer. For focus formation, 5 103 infected cells were plated in
triplicate onto 10-cm2 dishes. Cells were grown for 14 days in complete
medium and then were fixed with 100%methanol and stained for 30 min
with 50% Giemsa. For soft-agar colony formation, 1 103 infected cells
were seeded in triplicate on 60-mmdishes and allowed to grow for 21 days
in complete medium supplemented with fetal bovine serum and Noble
agar.
Apoptosis analysis. Infected MEFs were stained with fluorescein iso-
thiocyanate (FITC)-annexin V and propidium iodide using a Dead Cell
Apoptosis Kit (V13242; Molecular Probes/Invitrogen, Carlsbad, CA) ac-
cording to the manufacturer’s specifications. Cells were analyzed by flow
cytometry using a Becton Dickinson FACSCalibur cell sorter with CELL-
Quest Pro (version 5.2) analytical software.
Ribosome fractionation, RNA isolation, and qRT-PCR. Cells were
treated with cycloheximide (10 g/ml) for 5 min before being harvested.
Equal numbers of cells (3  106) were lysed, and cytosolic extracts were
subjected to ribosome fractionation as previously described (33, 46) using
a density gradient system (Teledyne ISCO, Lincoln, NE). RNA was iso-
lated from monosome, disome, and polysome fractions using RNAsolv
(Omega Bio-Tek, Norcross, GA) according to the manufacturer’s speci-
fications. Reverse transcription reactions were performed using a Super-
Script III first-strand synthesis system (Invitrogen, Carlsbad, CA) with an
oligo(dT) primer. Real-time PCR was performed on an iCycler apparatus
(Bio-Rad, Hercules, CA) using SsoFast EvaGreen Supermix (Bio-Rad,
Hercules, CA) to amplify Arf or Gapdh from monosome/disome and
polysome fractions. Numbers of Arf or Gapdh transcripts per fraction
were calculated from a standard curve generated from serial dilutions of a
known quantity of subcloned Arf or Gapdh cDNA. Arf or Gapdh mRNA
distribution per fraction was calculated as a percentage of the total num-
ber of transcripts in all collected fractions. For the ribosome profiling
analysis shown in Fig. 6, cells were treated with puromycin (Sigma, St.
Louis, MO) at a final concentration of 1 mM for 3 h.
Tumorigenic assay. Infected MEFs were trypsinized and counted. A
total of 2  106 cells were resuspended in PBS and injected subcutane-
ously into the left flank of athymic nude Foxn1nu/Foxn1numice. A sample
size of five mice per condition was used. Tumor growth was monitored
every day by palpation at the injection site, and the diameter of the tumors
was measured in two different planes using a digital caliper. Tumor vol-
ume was calculated with the following formula: (height2  length)/2,
where height represents the smaller of the two measurements.
Densitometry, image, and statistical analysis. Autofluorograms and
immunoblot filmswere scanned using an ImageScannerIII apparatus (GE
Healthcare, Piscataway, NJ), and densities were determined using Im-
ageQuant, version 2005 (GE Healthcare, Piscataway, NJ). Statistical anal-
yses were performed using a Student’s t test.
RESULTS
ARF is responsive to RasV12 and is functional in the absence of
Dmp1. Previous reports have demonstrated that ARF responds to
the RasV12 oncoprotein through a mechanism mediated by the
Dmp1 transcription factor (17, 18, 44). However, it was also noted
that ARF’s induction from RasV12 is compromised, but not com-
pletely lost, in the absence ofDmp1 (16, 18). We sought to further
understand the putative regulation and function of ARF in the
absence of cooperating transcriptional signals. Dmp1/ MEFs
were infected with a retrovirus encoding RasV12 and harvested at 5
days postinfection for gene expression analysis; confirmation of
Dmp1-null status of the MEFs was performed by PCR analysis of
reverse transcribed cDNA (Fig. 1A). Consistent with prior find-
ings (16, 18), we observed that ARF protein is still increased in
response to RasV12 overexpression in the absence of Dmp1 (Fig.
1B). Strikingly, Arf mRNA levels were not significantly altered
from RasV12 overexpression in Dmp1-deficient cells (Fig. 1C).
Collectively, these data indicate that transcriptional activation of
Arf gene expression is not obligatory for inducing ARF protein
levels in response to RasV12. These observations also indicate that
the Ras/Dmp1 pathway is not the only mechanism by which ARF
can sense the oncogenic cues of RasV12 signaling.
Since ARF is sensitive to the oncogenic stimulus of RasV12 in
Dmp1-null cells, we hypothesized that basal ARF could still exert
its important antiproliferative functions in these cells. To test this,
we infected Dmp1/ MEFs with a lentivirus encoding a short
hairpin targeting a scrambled control or Arf exon 1 (siScramble
and siARF, respectively) (1), the ARF-specific exon of the
CDKN2A locus. As shown by Western blot analysis, ARF protein
levels were dramatically reduced (90%) compared to those of
the scrambled control (Fig. 2A). To determine the effect of acute
knockdown of ARF on cellular proliferation, equal numbers of
Dmp1/MEFs expressing the short hairpin againstArf or scram-
bled control were seeded in triplicate, and total numbers of cells
were counted over 5 days. Acute knockdown of ARF significantly
increased the rate of proliferation of Dmp1/ MEFs (Fig. 2B).
Additionally, 5-bromodeoxyuridine (BrdU) incorporation was
alsomonitored tomeasure the extent of cells entering S phase (Fig.
2C andD). Acute knockdown of ARF caused a significant increase
in the percentage of cells undergoing DNA replication; this was
observed with both a short (2 h) and a longer (18 h) pulse of BrdU
(Fig. 2D and C, respectively). Acute knockdown of ARF did not
dramatically alter the amount of cells undergoing apoptosis (4.6%
for Dmp1/MEFs infected with siScramble-encoding virus and
3% for siARF-encoding virus) (Fig. 2E).
Ras/TSC/mTORC1 pathway can regulate ARF. Our data in-
dicate that ARF is induced in response to oncogenic RasV12 inde-
pendently of Dmp1 transcriptional activity.We hypothesized that
the mTORC1 signal transduction pathway could potentially reg-
ulate ARF expression. This critical cell growth regulatory pathway
coordinates ribosome biogenesis and mRNA translation. Regula-
Miceli et al.
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tion by this pathway is often associated with translational control
of target genes whose protein levels, but not mRNA levels, are
modulated in particular cellular contexts (10, 24, 43). To begin
evaluating this pathway, wild-type and Dmp1/ MEFs were
transduced with a retrovirus encoding RasV12 and subsequently
treated with rapamycin, the pharmacological inhibitor of
mTORC1 signaling, for 24 h prior to harvesting (Fig. 3A and B).
Repressed levels of phospho-S6K1 (Thr 389) and phospho-S6 (Ser
240/244) revealed that mTORC1 signaling was disrupted by rapa-
mycin exposure (Fig. 3A and B). For strains of both genotypes, the
induced levels of ARF protein expression were sensitive to rapa-
mycin treatment (Fig. 3A and B), suggesting that mTORC1 sig-
naling is essential for ARF’s induction from Ras.
We next wanted to interrogate the involvement of the Ras/
mTORC1 pathway in regulating ARF protein levels using genetic
manipulations. Tuberous sclerosis complex 1 (TSC1) is an up-
streammember of the mTORC1 pathway. TSC1 forms a complex
with TSC2 that negatively regulates mTORC1 signal transduction
(48).We hypothesized that activation of themTORC1pathway by
acute knockdown of TSC1 would induce ARF protein levels. To
test this, wild-typeMEFs were infected with lentiviruses encoding
small interfering RNAs (siRNAs) recognizing Tsc1. Two hairpins
were used to reduce TSC1 expression (Fig. 3C). ARF protein levels
were upregulated from transient knockdown of TSC1 in a dose-
dependent manner (Fig. 3C). Additionally, Tsc1flox/floxMEFs were
infected with adenoviruses encoding Cre recombinase or a
-galactosidase (LacZ) control. Enhanced levels of phospho-S6K1
(Thr 389) and phospho-S6 (Ser 240/244) demonstrated that hy-
peractivation of mTORC1 signaling occurred from loss of Tsc1
(Fig. 3D). Genetic ablation of Tsc1 also caused an increase in ARF
protein levels (Fig. 3D), corroborating the results observed from
using RNAi against Tsc1. Moreover, we infected wild-type MEFs
with Ad-LacZ or Ad-Cre to ensure that this finding was not a
nonspecific effect of Cre recombinase or the adenoviral infection
protocol (Fig. 3E). Additionally, Tsc1/flox and Tsc1flox/flox MEFs
were infected with Ad-Cre or Ad-LacZ to evaluate a dose-
dependent loss ofTsc1 on ARF protein levels (Fig. 3F). Loss of one
copy of Tsc1 was sufficient to induce ARF protein expression,
while loss of both copies of Tsc1 induced ARF protein expression
to a greater extent (Fig. 3F).
To investigate whether the ARF induction observed from the
loss of Tsc1 is dependent on TSC/mTORC1 signaling, we infected
Tsc1flox/flox MEFs with Ad-Cre or the Ad-LacZ control and then
treated them with rapamycin for 24 h prior to harvesting. Dimin-
ished levels of phospho-S6K1 (Thr 389) and phospho-S6 (Ser 240/
244) demonstrated that rapamycin successfully blockedmTORC1
signaling (Fig. 3G). As seen before with infection with a retrovirus
encoding RasV12 (Fig. 3A and B), ARF protein levels induced from
the loss of Tsc1 were sensitive to rapamycin treatment (Fig. 3G).
To confirm the contributions of mTORC1 signaling following
Tsc1 deletion to regulation of ARF, RNA interference was used to
acutely knockdownRaptor orRictor (Fig. 3H and I). Acute knock-
down of Raptor, but not Rictor, abrogated the induction of ARF
expression from the ablation of Tsc1 (Fig. 3H and I). These data
provide further support that mTORC1, but not mTORC2, is nec-
essary for mediating the induction of ARF from the loss of Tsc1.
Taken together, these data demonstrate that hyperactivation of
Ras/TSC/mTORC1 pathway can regulate ARF protein levels.
ARF induction from mTORC1 hyperactivation uses a novel
translational mechanism. Given that mTORC1 signal transduc-
tion plays a crucial role in the translational regulation of specific
mRNA transcripts, we hypothesized that this might be an under-
lying mechanism responsible for inducing ARF protein levels. To
test this, we assessed different aspects ofArf gene expression in the
face of mTORC1 hyperactivation. For each of these experiments,
Tsc1flox/floxMEFs were infected with Ad-Cre or Ad-LacZ as before.
Despite the increases in ARF protein expression, no significant
changes were observed in Arf mRNA levels following Tsc1 loss
(Fig. 4A). Next, we evaluated Arf mRNA stability and observed a
rate ofArfmRNA decay that was nearly identical in Ad-LacZ- and
Ad-Cre-infected Tsc1flox/flox cells (Fig. 4B). Moreover, the rate of
ARF protein decay was faster in Ad-Cre-infected Tsc1flox/floxMEFs
than in Ad-LacZ-infected cells (Fig. 4C and D), suggesting that a
higher rate of ARF protein must be synthesized in order to in-
FIG1 In the absence ofDmp1, RasV12 induces ARF protein, but not ARFmRNA. (A) First-strand cDNAwas synthesized from total RNA isolated fromwild-type
(WT) or Dmp1/MEFs, and endpoint PCR analysis was performed using primers specific for Dmp1 or Gapdh. PCRs were separated on an agarose gel and
stained with ethidium bromide. (B and C) Dmp1/ MEFs were transduced with retroviruses encoding an empty vector control (EV) or RasV12 and were
harvested at 5 days postinfection for gene expression analysis. (B) Infected cells were lysed, and separated proteins were immunoblotted for the indicated
proteins. Expression fold change over empty vector is indicated (B). First-strand cDNA was synthesized from isolated total RNA, and quantitative RT-PCR
analysis was performed. Arf mRNA levels were normalized to Gadph mRNA levels. Fold change was calculated using the CT method. Data are the mean
standard deviation of five independent experiments, and P values were calculated using the Student t test (C). (P), phosphorylated.
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crease steady-state levels in the cell. We also assessed the rate of
protein decay of ectopic HA-ARF expressed in Ad-Cre-infected
Tsc1flox/flox; Arf/ MEFs (Fig. 4E and F) and noted a similarly
accelerated half-life for HA-ARF (4 h). This observation sup-
ports the notion that ARF protein is being degraded at a high rate
in the absence ofTsc1 compared to ARF’s normally observed half-
life of6 h (25).
To further test the hypothesis that translational regulation
could be themolecular mechanism responsible for eliciting ARF’s
induction from mTORC1 hyperactivation, we assessed the asso-
ciation of Arf mRNA with actively translating polyribosomes. To
accomplish this task, cytosolic ribosomes were isolated by sucrose
gradient centrifugation from equal numbers of Dmp1/ MEFs
infected with a retrovirus encoding either RasV12 or an empty
vector control (Fig. 5A and B). Ribosomal subunits were detected
by measuring RNA absorbance at 254 nm by continuous UV
monitoring (Fig. 5B). To assess the distribution of Arf mRNA
transcripts in individual fractions comprising isolated mono-
somes, disomes, or polysomes, total RNA was isolated from each
sucrose gradient fraction, and Arf mRNA levels were determined
with qRT-PCR. Strikingly, Arf mRNA transcripts associated with
different polyribosome fractions in Dmp1-null cells infected with
retroviruses encoding RasV12 and empty vector (Fig. 5C). In
Dmp1/ MEFs infected with a RasV12-encoding retrovirus, Arf
mRNA was pooled to a heavier polyribosome fraction, indicating
that there is a greater extent of Arf mRNAs being actively trans-
lated by multiple ribosomes (more ribosomes associated per
mRNA) in these cells (Fig. 5C). These data support the hypothesis
that ARF is translationally regulated in the presence of oncogenic
RasV12 signals.
To address the possibility that general gains in global protein
translation could account for the increased translation of Arf
mRNA transcripts, we evaluated the distribution ofGapdhmRNA
in sucrose gradient fractions in Dmp1/ MEFs infected with a
retrovirus encoding either RasV12 or an empty vector control (Fig.
5D). No dramatic differences in the distribution ofGapdhmRNA
transcripts were observed across isolatedmonosomes or polyribo-
somes, in contrast to the distribution observed forArfmRNA(Fig.
FIG 2 ARF remains functional in the absence of Dmp1. Dmp1/ MEFs were infected with lentiviruses encoding a short hairpin against Arf (siARF) or the
siScramble control (siScr). (A) Infected cells were lysed, and separated proteins were immunoblotted for the indicated proteins. Expression fold change over the
siScramble control is indicated. (B) A total of 5  104 cells were seeded in triplicate for each indicated time point. Cells were trypsinized and counted with a
hemacytometer each day for 5 days thereafter. (C and D) Infected cells were seeded on coverslips and were pulsed with BrdU for 18 or 2 h, as indicated. Indirect
immunofluorescence analysis was used to score BrdU incorporation. Representative data are depicted as the mean standard deviation of 50 nuclei counted in
triplicate, and P values were calculated using the Student t test. (E) Infected cells were harvested and stained with FITC-annexin V and propidium iodide and
subjected to flow cytometry analysis. Representative data are expressed as the mean standard deviation of 10,000 events performed in triplicate, and P values
were calculated using the Student t test.
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5C). This suggests that the gain in Arf mRNA association with
actively translating polyribosomes is a selective phenotype caused
by RasV12 oncogenic signaling in the absence of Dmp1.
To confirm that ArfmRNA transcripts are actually associating
with actively translating polyribosomes, we assessed whether pu-
romycin could release Arf mRNA transcripts from the polyribo-
some fractions. Puromycin treatment causes a block in translation
elongation and a premature release of the nascent polypeptide
chain from actively translating polyribosomes (2, 45). To accom-
plish this,Dmp1/MEFs were infected with blasticidin-resistant
retroviral constructs encoding either GFP or RasV12. Consistent
with earlier findings, ARF protein is increased in response
to RasV12 overexpression in the absence of Dmp1 (Fig. 6A).
Dmp1/ MEFs infected with a retrovirus encoding GFP or
RasV12 were treated with 1 mM puromycin for 3 h (45, 49). Cyto-
solic ribosomes were isolated by sucrose gradient centrifugation
from equal numbers of cells, and ribosomal subunits were moni-
tored as before (Fig. 6B).Dmp1/MEFs treated with puromycin
FIG 3 Ras/TSC/mTORC1 pathway can regulate ARF. Infected cells were lysed, and separated proteins were immunoblotted for the indicated proteins.
Expression fold change over empty vector (EV), siScramble, or LacZ control is indicated. (A and B) WT or Dmp1/ MEFs were infected with retroviruses
encoding an empty vector control or RasV12 and were harvested at 5 days postinfection. RasV12-infected cells were treated with 100 nM rapamycin (R) or vehicle
(V) for 24 h prior to harvesting. (C) Wild-type MEFs were infected with lentiviruses encoding short hairpins against Tsc1 or the siScramble control and were
harvested at 7 days postinfection. (D to F) Tsc1flox/flox, WT, or Tsc1/floxMEFs (as indicated) were infected with adenoviruses encoding-galactosidase (LacZ) or
Cre recombinase and were harvested at 9 days postinfection. (G to I) Tsc1flox/flox MEFs were infected with adenoviruses encoding -galactosidase (LacZ) or Cre
recombinase and harvested at 9 days postinfection. (G) Ad-Cre-infected cells were treated with 100 nM rapamycin (R) or vehicle (V) control for 24 h prior to
harvesting. (H and I) Ad-Cre-infected cells were then transduced with viruses encoding short hairpins recognizing Raptor (siRaptor) or Rictor (siRictor) or a
luciferase control (siLUC) at 5 days postinfection and then harvested at 9 days postinfection for Western blot analysis. P, phosphorylated.
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and infected with GFP- and RasV12-encoding retroviruses showed
dramatic increases in the amplitude of the 80S peak, alongwith the
complete disappearance of the polysome peaks (Fig. 6B). Arf
mRNA distribution in fractions was then determined (Fig. 6C
and D). Arf mRNA distribution in puromycin-treated, GFP-
expressing cells mimicked the distribution of Arf mRNA in un-
treated GFP-expressing cells (Fig. 6C). This surprising finding
suggests that Arf mRNA found on the polysome peaks in these
GFP-expressing cells could in fact be “pseudo-polysomes” as op-
posed to actual polyribosomes (49). In contrast, puromycin treat-
ment released ArfmRNA from the polysome peaks in Dmp1/
MEFs infected with RasV12-encoding retrovirus(Fig. 6D), indi-
cating that Arf mRNA transcripts are indeed associating with
actively translating polyribosomes in response to oncogenic
RasV12 signaling.
To determine whether inhibition of mTORC1 signaling could
similarly displace Arf mRNA distribution from polysome peaks,
Dmp1/ MEFs were transduced with a retrovirus encoding
FIG 4 Loss of Tsc1 does not induce ARF through transcription, mRNA stability, or protein stability. (A to D) Tsc1flox/flox MEFs were infected with adenoviruses
encoding-galactosidase (LacZ) or Cre recombinase and were harvested at 9 days postinfection for gene expression analysis. First-strand cDNAwas synthesized
from isolated total RNA, and quantitative RT-PCR analysis was performed. Arf mRNA levels were normalized to Gadph mRNA levels (A). Fold change was
calculated using the CT method. Data are the mean standard deviation of three independent experiments, and P values were calculated using the Student
t test. (B) Cells were treated with 4 g/ml actinomycin D for the indicated time points. First-strand cDNA was synthesized from isolated total RNA, and
quantitative RT-PCR analysis was performed as described for panel A. Data are represented as percent remaining of Arf mRNA normalized to Gadph levels
relative to the respective zero hour treatment. (C) Cells were treated with 25 g/ml cycloheximide (CHX) and were harvested at the indicated time points for
Western blot analysis. Representative immunoblots are depicted. Densitometry quantification of immunoblots from panel C is depicted in panel D. Data are
represented as percent remaining of ARF protein levels normalized to tubulin protein levels relative to the respective 0-h treatment. (E and F) Tsc1flox/flox or
Tsc1flox/flox; Arf/ MEFs were infected with adenoviruses encoding -galactosidase (LacZ) or Cre recombinase and retroviruses encoding an empty vector
control or HA-ARF, as indicated. Cells were treated with 25 g/ml cycloheximide and were harvested at the indicated time points for Western blot analysis.
Representative immunoblots are depicted. In panel F, densitometry quantification of the immunoblots shown in panel E is depicted for cells infected with a
retrovirus encoding HA-ARF. Data are represented as percent remaining of HA-ARF protein normalized to tubulin protein levels relative to the 0-h treatment.
t1/2, half-life.
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FIG 5 ArfmRNA association with actively translating polyribosomes increases from RasV12 signaling in the absence ofDmp1.Dmp1/MEFs were transduced
with retroviruses encoding an empty vector control (EV) or RasV12 andwere harvested at 5 days postinfection. Cytosolic extracts from equal number of cells (3
106) treated for 5minwith cycloheximide (10g/ml) were separated on 7 to 47% sucrose gradients with constant UVmonitoring (254 nm). (A) Excess cells were
lysed, and separated proteins were immunoblotted for the indicated proteins. (B) A representative graph depicts the A254 absorbance of ribosome subunits over
increasing sucrose density. (C) Total RNA was isolated from each sucrose gradient fraction, and first-strand cDNA was synthesized for each fraction.
Monosome-, disome-, and polysome-associatedArfmRNA levels weremeasuredwith qRT-PCR andwere calculated as a percentage of totalArfmRNA collected
in all fractions. Data are the mean standard error of the mean of three independent experiments. (D) Monosome-, disome-, and polysome-associated Gapdh
mRNA levels were measured as described for panel C.
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RasV12 and subsequently treated with rapamycin for 24 h prior to
harvesting. Ribosomal subunits weremonitored as before (Fig. 7A
and B). Although rapamycin did not completely displace Arf
mRNA from translating polyribosomes, rapamycin treatment did
shift Arf mRNA away from the heavy polyribosome fractions,
where it accumulates in response to RasV12 (Fig. 7C). This finding
demonstrates the sensitivity of ArfmRNA association with trans-
lating polyribosomes to rapamycin exposure. To further interro-
gate the effects of mTORC1 signaling on the association of Arf
mRNA with actively translating polyribosomes, Tsc1flox/flox MEFs
FIG 6 ArfmRNA association with actively translating polyribosomes caused by hypergrowth stimuli can be disrupted with puromycin exposure. Retroviruses
were generated with pWZL-GFP-IRES-blast or pWZL-RasV12-IRES-blast. Dmp1/ MEFs were transduced with these retroviruses, and infected cells were
analyzed at 5 days postinfection. Cells were treated with 1 mM puromycin for 3 h, and then cytosolic extracts from equal numbers of cells (3 106) treated for
5minwith cycloheximide (10g/ml)were separated on 7 to 47% sucrose gradientswith constantUVmonitoring (254 nm). (A) Excess untreated cells were lysed,
and separated proteins were immunoblotted for the indicated proteins. (B) A representative graph depicts the A254 absorbance of ribosome subunits over
increasing sucrose density. (C) Total RNA was isolated from each sucrose gradient fraction, and first-strand cDNA was synthesized for each fraction.
Monosome-, disome-, and polysome-associatedArfmRNA levels weremeasuredwith qRT-PCR andwere calculated as a percentage of totalArfmRNA collected
in all fractions. (D) Monosome-, disome-, and polysome-associated ArfmRNA levels were measured as described for panel C.
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were infected with Ad-Cre or the Ad-LacZ control and were sub-
jected to ribosome profiling (Fig. 8A and B). We found that more
ArfmRNApooled to heavier polyribosome fractions upon the loss
of Tsc1 (Fig. 8C). Taken together, these findings support the hy-
pothesis that ARF is translationally regulated in the presence of
hyperactivated Ras/TSC/mTORC1 signaling.
ARF induction activates a p53 response. To determine
whether the ARF protein translationally induced from Tsc1 loss is
functional, we assessed several aspects of ARF biology. ARF binds
to and sequesters MDM2 in the nucleolus, allowing p53 protein
levels to accumulate and become active in the nucleoplasm (53).
Tsc1flox/flox MEFs infected with Ad-Cre or the Ad-LacZ control
were analyzed forMDM2 and ARF colocalization (Fig. 9A and B).
In both Ad-Cre- and Ad-LacZ-infected cells, ARF exhibited nu-
FIG 7 Arf mRNA is partially displaced from actively translating polyribosomes by rapamycin exposure. Dmp1/ MEFs were transduced with retroviruses
encoding an empty vector control (EV) or RasV12 andwere harvested at 5 days postinfection. Cells infected with RasV12-encoding virus were treated with 100 nM
rapamycin (R) or vehicle (V) for 24 h prior to harvesting. Cytosolic extracts from equal numbers of cells (3  106) treated for 5 min with cycloheximide (10
g/ml) were separated on 7 to 47% sucrose gradients with constant UV monitoring (254 nm). (A) Excess cells were lysed, and separated proteins were
immunoblotted for the indicated proteins. (B)A representative graph depicts theA254 absorbance of ribosome subunits over increasing sucrose density. (C)Total
RNAwas isolated from each sucrose gradient fraction, and first-strand cDNAwas synthesized for each fraction.Monosome-, disome-, and polysome-associated
ArfmRNA levels were measured with qRT-PCR and were calculated as a percentage of total ArfmRNA collected in all fractions. Data are the mean standard
error of the mean of three independent experiments. (P), phosphorylated.
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cleolar subcellular localization (Fig. 9A and B). Furthermore, we
found that ARF and MDM2 had increased colocalization in nu-
cleoli in Ad-Cre-infected Tsc1flox/flox MEFs compared to levels in
Ad-LacZ-infected cells (Fig. 9A and B). Next, ARF-MDM2 com-
plexes were immunoprecipitated from infected Tsc1flox/flox lysates
with a polyclonal antibody recognizing ARF and immunoblotted
forMDM2 (Fig. 9C). Induced ARF protein displayed strong bind-
ing toMDM2 in Ad-Cre-infected Tsc1flox/floxMEFs (Fig. 9C). Col-
lectively, these data suggest that the loss of Tsc1 increases ARF
protein expression and its ability to bind to and relocalize MDM2
into the nucleolus.
To examine whether this increase in ARF-MDM2 binding re-
sulted in p53 activation, infected Tsc1flox/flox lysates were probed
for p53 and two of its downstream target genes, p21 and MDM2.
p53, MDM2, and p21 displayed 2-fold increases in protein levels
following Tsc1 loss (Fig. 9D). Similarly, the induction of p53, p21,
and MDM2 was completely abrogated in Ad-Cre-infected
Tsc1flox/flox;Arf/MEFs (Fig. 9D), implying that ARF is necessary
for facilitating the induction of p53 and its target genes in response
to Tsc1 loss. Alternatively, infected Tsc1flox/flox MEFs were treated
with rapamycin 24 h prior to harvesting. The induction of ARF
caused by the loss of Tsc1 was disrupted due to rapamycin expo-
FIG 8 ArfmRNA association with actively translating polyribosomes increases from the loss ofTsc1.Tsc1flox/floxMEFs were infected with adenoviruses encoding
-galactosidase (LacZ) or Cre recombinase and harvested at 9 days postinfection. Cytosolic extracts from equal numbers of cells (3 106) treated for 5min with
cycloheximide (10 g/ml) were separated on 7 to 47% sucrose gradients with constant UV monitoring (254 nm). (A) Excess cells were lysed, and separated
proteins were immunoblotted for the indicated proteins. (B) A representative graph depicts the A254 of ribosome subunits over increasing sucrose density. (C)
Total RNA was isolated from each sucrose gradient fraction, and first-strand cDNA was synthesized for each fraction. Monosome-, disome-, and polysome-
associated ArfmRNA levels were measured with qRT-PCR and were calculated as a percentage of total ArfmRNA collected in all fractions.
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sure (Fig. 9E), and, consequently, the induction of p53, p21, and
MDM2 was similarly abrogated in the absence of ARF induction
(Fig. 9E).
ARF/p53 response causes cell cycle arrest. Given that hyper-
activation of mTORC1 signaling increases ARF protein expres-
sion and that ARF induces p53 and its downstream targets, we
hypothesized that ARF was responsible for eliciting a cell cycle
arrest in response to mTORC1 hyperactivation. To test this, cell
proliferation was monitored each day for 6 days. The rate of pro-
liferation of Ad-Cre-infected Tsc1flox/flox MEFs was markedly re-
duced compared to that of Ad-LacZ-infected cells (Fig. 10A and
B), consistent with the ARF-dependent activation of p53 (Fig. 9).
However, this proliferation defect was absent upon Tsc1 loss in
cells also lackingArf (Fig. 10B). Of note, changes in cell death (Fig.
10C) do not account for the decrease in total cell number observed
in Ad-Cre-infected Tsc1flox/flox cells. Additionally, BrdU incorpo-
ration was measured (Fig. 10D). As seen before, Ad-Cre-infected
Tsc1flox/flox MEFs exhibited a significant decrease in BrdU incor-
poration compared to Ad-LacZ-infected cells (Fig. 10D). Notably,
this decrease was completely rescued in the absence of Arf (Fig.
10D). Furthermore, acute knockdown of TSC1 reduced BrdU in-
corporation in wild-type MEFs (Fig. 10E), corresponding with
their dose-dependent induction of ARF protein (Fig. 3C).
Since ARF serves to prevent proliferation in response to loss of
Tsc1, we hypothesized that removal of ARF would permit cells
with hyperactivated mTOR to proliferate long-term without be-
ing properly checked. To test this, Tsc1flox/flox; Arf/MEFs were
infected with Ad-Cre or the Ad-LacZ control and subjected to
long-term focus formation analysis (Fig. 10F andG). Significantly
more foci formed by hyperactivating mTOR signaling in Arf/
cells, and there was an increase in total focus area (Fig. 10H and I).
Taken together, this indicates that ARF keeps cell proliferation in
check by responding to heightened levels ofmTORC1 signaling to
induce cell cycle arrest.
Translationally regulatedARF represses transformation and
tumorigenesis. The observation that ARF induces a p53-mediated
cell cycle arrest in response to hypergrowth cues emanating from
hyperactivation of mTORC1 signal transduction led us to test the
hypothesis that ARF could inhibit transformation and tumorigenesis
in response to these hypergrowth cues.We infectedDmp1/MEFs
orArf/MEFswitha retrovirus encodingRasV12 or anemptyvector
control andassessedanchorage-independentgrowth in soft agar (Fig.
11A). In MEFs infected with RasV12-encoding virus, Dmp1/ cells
formed significantly fewer colonies in soft agar thanArf/ cells (Fig.
11B). To determine if the induced levels of ARF in Dmp1/MEFs
infected with RasV12-encoding virus were responsible for the inhibi-
tion of colony formation, infected Dmp1/MEFs were also trans-
ducedwith virus encoding an siRNArecognizingARFor a scrambled
FIG 9 ARF induced from hypergrowth stimuli activates a p53 response. Tsc1flox/flox MEFs were infected with adenoviruses encoding -galactosidase (LacZ) or
Cre recombinase and were harvested at 9 days postinfection for analysis. (A) Infected cells were seeded onto coverslips, fixed, and stained for indirect immu-
nofluorescence analysis with specific primary antibodies for ARF andMDM2and forAlexa Fluor 594 andAlexa Fluor 488, respectively. Cells were counterstained
for nuclei with SlowFade Gold Antifade mounting reagent with DAPI. (B) Quantification of nucleolar ARF-MDM2 colocalization is depicted from indirect
immunofluorescence analysis as described for panel A. Representative data are expressed as themean standard deviation of 50 nuclei counted in triplicate, and
P values were calculated using the Student t test. (C) Lysates from infected cells were immunoprecipitated with a rabbit polyclonal antibody directed against ARF
or normal rabbit IgG. Proteins immune complexes were separated, transferred to PVDFmembranes, and immunoblotted with the indicated antibodies. (D and
E) Infected cells were lysed, and separated proteins were immunoblotted for indicated proteins. Expression fold change over the LacZ control is indicated (D).
Ad-Cre-infected cells were treated with 100 nM rapamycin (R) or vehicle (V) control for 24 h prior to harvesting (E).
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control. Knockdown of ARF restored the ability of Dmp1/MEFs
infected with RasV12-encoding virus to form colonies in soft agar,
thereby phenocopying the colony-forming potential of infected
Arf/MEFs (Fig. 11B).Nodramatic changes in apoptotic cell death
were observed, suggesting that changes in cell death do not account
for the differences observed in colony formation (Fig. 11C).
To determine whether translationally regulated ARF could
repress tumorigenesis in an allograft model, we assessed tumor
formation and burden of Dmp1/ or Arf/ MEFs infected
with RasV12-encoding virus by subcutaneously injecting MEFs
into the flanks of nude mice (Fig. 11D and E); as before,
Dmp1/ MEFs were also infected with a virus encoding an
siRNA recognizing ARF or a scrambled control (siScramble) in
order to determine the specificity of ARF’s involvement in pre-
venting tumorigenesis (Fig. 11E, inset). Strikingly, tumor onset
and growth were markedly reduced in mice injected with
Dmp1/MEFs infected with siScramble-encoding virus com-
pared to Arf/ MEFs (Fig. 11D and E). Furthermore, acute
FIG 10 ARF/p53 response induces a cell cycle arrest. (A to D) Tsc1flox/flox or Tsc1flox/flox; Arf/MEFs were infected with adenoviruses encoding -galactosidase
(LacZ) or Cre recombinase as indicated. Infected cells were lysed, and separated proteins were immunoblotted for indicated proteins (A). A total of 1 105 cells
were seeded in triplicate for each indicated time point at 5 days postinfection. Cells were then trypsinized and counted with a hemacytometer each day for 6 days
thereafter (B). Infected cells were harvested and stainedwith FITC-annexinV and propidium iodide and subjected to flow cytometry analysis (C). Representative
data are depicted as the mean standard deviation of 10,000 events performed in triplicate. (D) Infected cells were seeded on coverslips at 9 days postinfection.
On day 10 postinfection, cells were pulsed with BrdU for 4 h. Indirect immunofluorescence analysis was used to score BrdU incorporation. Representative data
are expressed as themean standard deviation of 50 nuclei counted in triplicate, and P values were calculated using the Student t test. (E)Wild-typeMEFs were
infected with lentiviruses encoding short hairpins against Tsc1 or the siScramble control and were seeded on coverslips at 7 days postinfection for BrdU
incorporation. Cells were pulsed with BrdU for 18 h, and analysis was performed as described for panel D. (F to I) Tsc1flox/flox; Arf/MEFs were infected with
adenoviruses encoding -galactosidase (LacZ [L]) or Cre recombinase (C) as indicated. A total of 5 103 cells were seeded in triplicate onto 10-cm2 dishes for
focus formation analysis. Infected cells were lysed, and separated proteins were immunoblotted for the indicated proteins (F). Cells were grown for 14 days in
complete medium and were fixed and stained with Giemsa (G). Panels H and I show, respectively, the quantification of the total number of foci and total focus
area of representative images from panel G. (P), phosphorylatd.
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knockdown of ARF in Dmp1/ MEFs restored the tumori-
genic potential of these cells, partially phenocopying the tumor
burden observed in Arf/ MEFs infected with RasV12-
encoding virus (Fig. 11D and E). Collectively, these data sup-
port the model that ARF acts as a critical checkpoint against
hypergrowth stimuli and that in response to these stimuli, ARF
can repress cellular transformation (Fig. 12).
DISCUSSION
ARF is a key tumor suppressor responsible for safeguarding the
cell against oncogenic stimuli. While it has long been appreciated
that ARF can inhibit cell cycle progression, both through p53-
dependent and p53-independent mechanisms, the context of
stimuli to which ARF responds has predominantly been catego-
rized as hyperproliferative cues. Our results now demonstrate that
FIG 11 ARF induced fromhypergrowth cues can repress oncogenic transformation.Arf/ orDmp1/MEFswere infectedwith lentivirus encoding an empty vector
control or RasV12.Dmp1/MEFs were also infected with lentiviruses encoding short hairpin against Arf or the siScramble control, as indicated. (A and B) A total of
1 103 cells were seeded in triplicate inmedium containing soft agar and were assessed for colony formation 21 days later. (A) Infected cells were lysed, and separated
proteins were immunoblotted for indicated proteins. Representative images of colonies are also depicted. (B) Quantification of the number of colonies. Representative
data are expressed as the mean  standard deviation, and P values were calculated using the Student t test. (C) Infected cells were harvested and stained with
FITC-annexin V and propidium iodide and subjected to flow cytometry analysis. Representative data are expressed as themean standard deviation of 10,000 events
performed in triplicate. (D andE)A total of 2 106 cells infectedwith lentivirus encodingRasV12 were subcutaneously injected into the left flank of athymic nudemice.
Five mice were injected per condition, such that eachmouse received one injection site. (D) Images of mice and excised tumors are depicted. (E) Tumor diameter was
measured in twoplaneswith adigital caliper on successivedayspostinjection.Tumorvolume is expressed as themean standard errorof themean.Excess infected cells
from the day of injection were lysed, and separated proteins were immunoblotted for indicated proteins (inset).
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ARF has a novel and important role sensing unwarranted hyper-
growth stimuli, such as those emanating from robust activation of
the mTORC1 signaling pathway. Given that cellular growth and
proliferation are in fact two distinct biological processes, albeit
highly integrated, we envision a broader range of oncogenic stim-
uli to which ARF can respond in its antitumorigenic efforts. Since
oncogenic stimuli provide the selective pressure for the outgrowth
of cancer cells that evade ARF tumor suppression (50), it is im-
portant to better understand the array of oncogenic stimuli that
are susceptible to ARF tumor surveillance.
In agreement with other groups, we observed that ARF is still
capable of responding toRasV12 without transcriptional induction
of Arf mRNAs by Dmp1. We found that the mTORC1 pathway
regulates ARF protein levels through a novel translational mech-
anism; Arf mRNA showed enhanced association with actively
translating polyribosomes in response to RasV12 and Tsc1 loss.
ARF induced fromTsc1 loss facilitated p53 pathway activation and
cell cycle arrest. Furthermore, translationally regulated ARF pro-
tein repressed anchorage-independent colony formation in soft
agar and tumor burden in an allograft model. Therefore, we pro-
pose that the cell utilizes this ARF checkpoint as a means to keep
excessive progrowth cues under scrutiny.
Of note, Tsc1/MEFs have been reported to display a lower
proliferative rate thanTsc1/ orTsc1/MEFs (26). Also, Zhang
et al. have shown that primary Tsc2/MEFs display early senes-
cence in conjunction with a higher expression of p21 (55). Our
data suggest that this increase in p21 and the resultant decrease in
proliferation could be facilitated in part by the translational ARF
induction that ensues from the activation of mTORC1; we ob-
served that p21 induction was abrogated upon the removal of Arf
inTsc1/ cells and that loss ofArf rescued the proliferation defect
observed in cells lacking Tsc1.
We envisage collaboration between the Ras/TSC/mTORC1
and the Ras/Dmp1 pathways which together coordinate ARF in-
duction from oncogenic RasV12 overexpression. The involvement
of the mTORC1 pathway could explain why RasV12-mediated
ARF induction is compromised, but not completely lost, in a
Dmp1/ setting. Given the absolute necessity for cancer cells to
bypass ARF’s checkpoint against oncogenic stimuli, it is not sur-
prising that multiple regulatory mechanisms would allow ARF to
sense as many oncogenic cues as possible.
Deregulation of the members of the mTOR pathway is impli-
cated in the mechanism driving hamartoma-forming diseases.
Tuberous sclerosis complex is characterized by the potential for
hamartoma formation in a wide spectrum of organs (14). Loss or
reduction in function of the TSC1-TSC2 protein complex and the
resulting constitutivemTOR signaling are the contributing factors
for this disease (6). Our finding that loss of Tsc1 induces an ARF
response could give some insight as towhy benign hamartomas, as
opposed to more aggressive neoplastic tumors, arise in this dis-
ease. It is possible that the ARF growth checkpoint could play a
putative role in repressing the proliferation of hamartoma-
forming cells, thereby inhibiting their progression to a more ag-
gressive neoplastic tumor; these hypotheses would need to be for-
mally tested. It is of note that analysis of pleomorphic
xanthoastrocytoma (PXA), a rare astrocytic tumor in the cerebral
hemispheres of children and young adults, was reported to have
homozygous deletion of theCDKN2A/p14Arf andCDKN2B loci as
well as reduced Tsc1 mRNA expression as defining molecular al-
terations (54). This finding suggests that concomitant loss of Tsc1
and Arf can contribute to the mechanisms driving tumorigenesis.
In the current study, we have described the involvement of the
mTORC1 pathway in the regulation of the ARF tumor suppressor
via a translational mechanism. It has been readily shown that
mTORC1 signaling can induce the selective translation of specific
mRNA targets. One such example is the stimulation of p53 trans-
lation that occurs upon the loss of Tsc1 in response to stress con-
ditions (27). It was shown that mTOR can regulate p53 protein
synthesis and that hyperactivation of the mTOR pathway can in-
crease sensitivity to DNA damage and energy starvation. In fact,
other reports have further elucidated potential mechanisms by
which p53 can be translationally regulated (5, 47). Additionally,
mTORC1 signaling has been reported to specifically modulate the
translation ofmyeloid cell leukemia sequence 1 (Mcl-1) (32). Loss
ofTsc2 in E-Myc cells increases the translation ofMcl-1, and this
modulation of Mcl-1 by mTORC1 is relevant to the chemo-
sensitivity of these tumors. Also, mTORC1 signal transduction
modulates the translation of nucleophosmin through a mecha-
nism mediated by FBP1 acting as a regulatory RNA binding pro-
tein (33, 35). Here, we show that ARF is another translationally
regulated gene product as Arf mRNA has enhanced association
with actively translating polyribosomes in response to enhanced
mTORC1 signal transduction. Translational control of ARF, as
well as of these other translationally regulated mRNAs, can serve
as a versatile and robust mode of regulation for essential cellular
functions.
Further elucidation of themolecularmechanismdrivingARF’s
responsiveness to mTORC1 signaling is of great significance. The
implications include the potential identification of novel down-
stream players not otherwise thought of in the context of the ARF/
p53 regulatory network whose interrogation could potentially
open avenues to new cancer therapeutics.
ACKNOWLEDGMENTS
We thank all the members of the Weber lab for their comments and
technical assistance. We also thank David Kwiatkowski and Jeffrey Arbeit
for the Tsc1flox/flox mice, Robert Weinberg for the pWZL-GFP-IRES-blast
and pWZL-RasV12-IRES-blast constructs, and Martine Roussel for the
pBabe-puro-RasV12 construct. We are very grateful to David Beebe, Jef-
frey Arbeit, Ron Bose, and Fanxin Long for insightful discussions.
A.P.M. was supported by Department of Defense Breast Cancer Re-
search Program award X81XWH-08-BCRP-PREDOC. A.J.S. was sup-
FIG 12 Model. Hypergrowth stimuli emanating from hyperactivation of the
mTORC1 pathway induce an ARF checkpoint through a novel translational
mechanism. In response to these oncogenic cues, ARF can activate a p53-
mediated cell cycle arrest that represses cellular transformation.
Miceli et al.
362 mcb.asm.org Molecular and Cellular Biology
 o
n








ported by Komen for the Cure grant KG091234. This work was supported
by NIH grant CA120436 and an Era of Hope Scholar Award in Breast
Cancer Research (BC007304) to J.D.W.
Views and opinions of, and endorsements by, the authors do not re-
flect those of the U.S. Army or the Department of Defense.
REFERENCES
1. Apicelli AJ, et al. 2008. A non-tumor suppressor role for basal p19ARF in
maintaining nucleolar structure and function. Mol. Cell. Biol. 28:
1068–1080.
2. Azzam ME, Algranati ID. 1973. Mechanism of puromycin action: fate of
ribosomes after release of nascent protein chains from polysomes. Proc.
Natl. Acad. Sci. U. S. A. 70:3866–3869.
3. Bates S, et al. 1998. p14ARF links the tumour suppressors RB and p53.
Nature 395:124–125.
4. Brady SN, Yu Y, Maggi LB, Jr, Weber JD. 2004. ARF impedes NPM/B23
shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol. Cell.
Biol. 24:9327–9338.
5. Chen J, Kastan MB. 2010. 5=-3=-UTR interactions regulate p53 mRNA
translation and provide a target for modulating p53 induction after DNA
damage. Genes Dev. 24:2146–2156.
6. Crino PB, Nathanson KL, Henske EP. 2006. The tuberous sclerosis
complex. New Engl. J. Med. 355:1345–1356.
7. Dai Y, Grant S. 2010. New insights into checkpoint kinase 1 in the DNA
damage response signaling network. Clin. Cancer Res. 16:376–383.
8. de Stanchina E, et al. 1998. E1A signaling to p53 involves the p19(ARF)
tumor suppressor. Genes Dev. 12:2434–2442.
9. Elledge SJ. 1996. Cell cycle checkpoints: preventing an identity crisis.
Science 274:1664–1672.
10. Grech G, et al. 2008. Igbp1 is part of a positive feedback loop in stem cell
factor-dependent, selective mRNA translation initiation inhibiting ery-
throid differentiation. Blood 112:2750–2760.
11. Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer.
Cancer Cell 12:9–22.
12. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next genera-
tion. Cell 144:646–674.
13. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes
Dev. 18:1926–1945.
14. Inoki K, Corradetti MN, Guan KL. 2005. Dysregulation of the TSC-
mTOR pathway in human disease. Nat. Genet. 37:19–24.
15. Inoki K, Guan KL. 2009. Tuberous sclerosis complex, implication from a
rare genetic disease to common cancer treatment. Hum. Mol. Genet. 18:
R94–100.
16. Inoue K, Mallakin A, Frazier DP. 2007. Dmp1 and tumor suppression.
Oncogene 26:4329–4335.
17. Inoue K, Roussel MF, Sherr CJ. 1999. Induction of ARF tumor suppres-
sor gene expression and cell cycle arrest by transcription factor DMP1.
Proc. Natl. Acad. Sci. U. S. A. 96:3993–3998.
18. Inoue K, et al. 2000. Disruption of the ARF transcriptional activator
DMP1 facilitates cell immortalization, Ras transformation, and tumori-
genesis. Genes Dev. 14:1797–1809.
19. Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ. 2001. Dmp1 is
haplo-insufficient for tumor suppression and modifies the frequencies of
Arf and p53 mutations in Myc-induced lymphomas. Genes Dev. 15:
2934–2939.
20. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. 1999.
Tumor spectrum in ARF-deficient mice. Cancer Res. 59:2217–2222.
21. Kamijo T, et al. 1997. Tumor suppression at the mouse INK4a locus
mediated by the alternative reading frame product p19ARF. Cell 91:
649–659.
22. Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature
432:316–323.
23. Kladney RD, et al. 2010. Tuberous sclerosis complex 1: an epithelial
tumor suppressor essential to prevent spontaneous prostate cancer in aged
mice. Cancer Res. 70:8937–8947.
24. KnaupKX, et al. 2009.Mutual regulation of hypoxia-inducible factor and
mammalian target of rapamycin as a function of oxygen availability. Mol.
Cancer Res. 7:88–98.
25. Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. 2004.
N-terminal polyubiquitination anddegradation of theArf tumor suppres-
sor. Genes Dev. 18:1862–1874.
26. Kwiatkowski DJ, et al. 2002. A mouse model of TSC1 reveals sex-
dependent lethality from liver hemangiomas, and up-regulation of p70S6
kinase activity in Tsc1 null cells. Hum. Mol. Genet. 11:525–534.
27. Lee CH, et al. 2007. Constitutive mTOR activation in TSC mutants
sensitizes cells to energy starvation and genomic damage via p53. EMBO J.
26:4812–4823.
28. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data
using real-time quantitative PCR and the 2CT method. Methods 25:
402–408.
29. Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated
translational control. Nat. Rev. Mol. Cell Biol. 10:307–318.
30. Reference deleted.
31. Reference deleted.
32. Mills JR, et al. 2008. mTORC1 promotes survival through translational
control of Mcl-1. Proc. Natl. Acad. Sci. U. S. A. 105:10853–10858.
33. Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD.
2011. Identification of FUSE-binding protein 1 as a regulatory mRNA-
binding protein that represses nucleophosmin translation. Oncogene 30:
77–86.
34. Palmero I, Pantoja C, Serrano M. 1998. p19ARF links the tumour sup-
pressor p53 to Ras. Nature 395:125–126.
35. Pelletier CL, et al. 2007. TSC1 sets the rate of ribosome export and protein
synthesis through nucleophosmin translation. Cancer Res. 67:1609–1617.
36. Proud CG. 2007. Signalling to translation: how signal transduction path-
ways control the protein synthetic machinery. Biochem. J. 403:217–234.
37. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. 1995. Alternative reading
frames of the INK4a tumor suppressor gene encode two unrelated pro-
teins capable of inducing cell cycle arrest. Cell 83:993–1000.
38. Radfar A, Unnikrishnan I, Lee HW, DePinho RA, Rosenberg N. 1998.
p19(Arf) induces p53-dependent apoptosis during abelson virus-
mediated pre-B cell transformation. Proc. Natl. Acad. Sci. U. S. A. 95:
13194–13199.
39. Roussel MF, Theodoras AM, Pagano M, Sherr CJ. 1995. Rescue of
defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci.
U. S. A. 92:6837–6841.
40. Saporita AJ, Maggi LB Jr, Apicelli AJ, Weber JD. 2007. Therapeutic
targets in the ARF tumor suppressor pathway. Curr. Med. Chem. 14:
1815–1827.
41. Shaw RJ, Cantley LC. 2006. Ras, PI(3)K and mTOR signalling controls
tumour cell growth. Nature 441:424–430.
42. Sherr CJ. 2006. Divorcing ARF and p53: an unsettled case. Nat. Rev.
Cancer 6:663–673.
43. Spriggs KA, Bushell M, Willis AE. 2010. Translational regulation of gene
expression during conditions of cell stress. Mol. Cell 40:228–237.
44. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K. 2005.
Ras-Raf-Arf signaling critically depends on theDmp1 transcription factor.
Mol. Cell. Biol. 25:220–232.
45. Stefani G, Fraser CE, Darnell JC, Darnell RB. 2004. Fragile X mental
retardation protein is associated with translating polyribosomes in neuro-
nal cells. J. Neurosci. 24:7272–7276.
46. Strezoska Z, Pestov DG, Lau LF. 2000. Bop1 is a mouse WD40 repeat
nucleolar protein involved in 28S and 5.8S RRNA processing and 60S
ribosome biogenesis. Mol. Cell. Biol. 20:5516–5528.
47. Takagi M, AbsalonMJ, McLure KG, KastanMB. 2005. Regulation of p53
translation and induction after DNA damage by ribosomal protein L26
and nucleolin. Cell 123:49–63.
48. Tee AR, et al. 2002. Tuberous sclerosis complex-1 and -2 gene products
function together to inhibit mammalian target of rapamycin (mTOR)-
mediated downstream signaling. Proc. Natl. Acad. Sci. U. S. A. 99:
13571–13576.
49. Thermann R, Hentze MW. 2007. Drosophila miR2 induces pseudo-
polysomes and inhibits translation initiation. Nature 447:875–878.
50. Volanakis EJ, Sherr CJ. 2010. Developmental strategies for evasion of Arf
tumor suppression. Cell Cycle 9:14–15.
51. Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA. 2003.
Ras modulates Myc activity to repress thrombospondin-1 expression and
increase tumor angiogenesis. Cancer Cell 3:219–231.
52. Weber JD, et al. 2000. Cooperative signals governing ARF-mdm2 inter-
action and nucleolar localization of the complex. Mol. Cell. Biol. 20:
2517–2528.
ARF Acts as a Hypergrowth Checkpoint
January 2012 Volume 32 Number 2 mcb.asm.org 363
 o
n








53. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. 1999. Nucleolar
Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20–26.
54. Weber RG, et al. 2007. Frequent loss of chromosome 9, homozygous
CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1mRNA expression
in pleomorphic xanthoastrocytomas. Oncogene 26:1088–1097.
55. Zhang H, et al. 2003. Loss of Tsc1/Tsc2 activates mTOR and disrupts
PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest.
112:1223–1233.
56. Zindy F, et al. 1998. Myc signaling via the ARF tumor suppressor regulates
p53-dependent apoptosis and immortalization.GenesDev. 12:2424–2433.
57. Zoncu R, Efeyan A, Sabatini DM. 2011.mTOR: from growth signal integration
to cancer, diabetes and ageing.Nat. Rev.Mol. Cell Biol. 12:21–35.
Miceli et al.
364 mcb.asm.org Molecular and Cellular Biology
 o
n
 January 11, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
